Correlating Receptor Status with Nottingham Prognostic Index in Breast Cancer

被引：0
|
作者：
Gupta, Rohan [1 ]
Khanna, Rahul [1 ]
Kar, Amrita G. [2 ]
Khanna, Seema [1 ]
Khanna, Siddharth [3 ]
Meena, Ram Niwas [1 ]
机构：
[1] Banaras Hindu Univ, Inst Med Sci, Dept Surg, Varanasi 221005, India
[2] Banaras Hindu Univ, Inst Med Sci, Dept Pathol, Varanasi 221005, India
[3] Aligarh Muslim Univ, Dept Ophthalmol, Aligarh 202002, India
来源：
INDIAN JOURNAL OF SURGERY | 2024年 / 86卷 / 02期
关键词：
Breast cancer; Nottingham Prognostic Index; Receptor status;
D O I：
10.1007/s12262-023-03865-2
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
The biological behavior and prognosis of breast cancer is often unpredictable with a number of factors contributing to the outcome. Nottingham's Prognostic Factor (NPI) takes into account the tumor size, nodal status, and histological grade of tumor. The receptor status considers the hormone receptor and HER2 status. The aim of the study was to correlate the NPI score with the receptor status expression in Indian women with breast cancer. A total of 78 breast cancer patients who underwent upfront modified radical mastectomy were recruited. NPI score and receptor status assessment was done at histopathological examination of the specimen. Hormone receptor negative breast cancer tended to have a higher NPI score compared to hormone receptor positive patients. However, this difference did not achieve statistical significance. NPI score parameters except for the histological grade are a reflection of the duration or time span of the tumor. On the contrary, the receptor status is indicative of the tumor biology and not of its time duration. A scoring system which incorporates the three parameters of the NPI as well as the receptor status would be the best prognostic index as well as predictive regarding the choice of adjuvant therapy.
引用
收藏
页码：344 / 347
页数：4
相关论文
共 50 条
  • [41] Classification of Breast Cancer Nottingham Prognostic Index Using High-Dimensional Embedding and Residual Neural Network
    Zhou, Li
    Rueda, Maria
    Alkhateeb, Abedalrhman
    CANCERS, 2022, 14 (04)
  • [42] Prognostic effect of estrogen receptor status across age in primary breast cancer
    Bentzon, Niels
    Duering, Maria
    Rasmussen, Birgitte Bruun
    Mouridsen, Henning
    Kroman, Niels
    INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (05) : 1089 - 1094
  • [43] Breast carcinoma grading, estimation of tumor size, axillary lymph node status, staging, and Nottingham Prognostic Index scoring on mastectomy specimens
    Ahmad, Zubair
    Khurshid, Amna
    Qureshi, Asim
    Idress, Romana
    Asghar, Nasira
    Kayani, Naila
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2009, 52 (04) : 477 - 481
  • [44] Prognostic impact of progesterone receptor status combined with body mass index in breast cancer patients treated with adjuvant aromatase inhibitor
    Ohara, Masahiro
    Akimoto, Etsushi
    Noma, Midori
    Matsuura, Kazuo
    Doi, Mihoko
    Kagawa, Naoki
    Itamoto, Toshiyuki
    ONCOLOGY LETTERS, 2015, 10 (05) : 3286 - 3292
  • [45] Prognostic and predictive factors in primary breast cancer and their role in patient management: The Nottingham Breast Team
    Rampaul, RS
    Pinder, SE
    Elston, CW
    Ellis, IO
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2001, 27 (03): : 229 - 238
  • [46] Correlation Between Nottingham Prognostic Index and Adjuvant! Online Prognostic Tools in Patients With Early-Stage Breast Cancer in Mid-Western Ireland
    Quintyne, Keith Ian
    Woulfe, Bernie
    Coffey, John C.
    Gupta, Rajnish K.
    CLINICAL BREAST CANCER, 2013, 13 (04) : 233 - 238
  • [47] Hormone Receptor Status in Breast Cancer and its Relation to Age and Other Prognostic Factors
    Pourzand, Ali
    Fakhree, M. Bassir A.
    Hashemzadeh, Shahryar
    Halimi, Monireh
    Daryani, Amir
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2011, 5 : 87 - 92
  • [48] Clinicopathological characteristics and prognostic analysis of breast cancer with a hormone receptor status of ER(-)/PR(+)
    Wang, Xinli
    Xue, Yan
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [49] Negative progesterone receptor status is an adverse prognostic factor for luminal B breast cancer
    Wu, Fan
    Huang, Weiwei
    Chen, Kan
    Li, Nani
    Liu, Jian
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (02): : 901 - 911
  • [50] Determination of GP88 (progranulin) expression in breast tumor biopsies improves the risk predictive value of the Nottingham Prognostic Index
    Serrero, Ginette
    Hawkins, Douglas M.
    Bejarano, Pablo A.
    Ioffe, Olga
    Tkaczuk, Katherine R.
    Elliott, Robert E.
    Head, Jonathan F.
    Phillips, Jeffrey
    Godwin, Andrew K.
    Weaver, JoEllen
    Hicks, David
    Yue, Binbin
    DIAGNOSTIC PATHOLOGY, 2016, 11
12345